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This research examines the assessment of military personnel for internal 
contamination after the detonation of a radiological dispersal device (RDD) in a combat 
environment.  Due to limited medical infrastructure in forward deployed and combat 
areas, the process of triaging personnel who receive contamination may be extremely 
difficult. The lack of resources and equipment to analyze samples and test personnel 
makes for a very time consuming process.   
Nearly all deployable Army units are equipped with AN/VDR-2 or AN/PDR-77 
military radiac detectors.  These detectors are capable of measuring the dose and dose 
rate for both gamma and beta radiation.  They can readily be used in combat 
environments to detect radiation since they are widely fielded and Army units already 
have a training requirement for their usage.   
In order to assess these detectors, a Monte Carlo radiation transport model was 
developed using specifications provided by Canberra, the instrument manufacturer [1].  
The Los Alamos National Laboratory Monte Carlo N-Particle Transport Code (MCNP) 
Version 5 was used [2].  This model was validated against experimental measurements 
using a polymethyl methacrylate (PMMA) slab phantom, and then used in simulations 
with Medical Internal Radiation Dose (MIRD) phantoms [3].  Four locations were 
evaluated on the MIRD phantoms: the posterior upper right torso, the anterior upper right 
torso, the lateral upper thigh, and the anterior of the neck.  Since this study targets 
military age males and females in satisfactory physical condition, only the reference male 









Ir, were selected and evaluated due to their 
assessment as candidate battlefield RDD isotopes, as well as their ability to be detected 
using an AN/VDR-2 and AN/PDR-77 [4].  The distribution and kinetic transport of these 
isotopes throughout the body, over a period of time, was determined using the Oak Ridge 
National Laboratory Dose Calculation and Risk Software (DCAL) [5]. Using Monte 
Carlo simulations, the radiac dose rate reading was determined for each isotope, at each 
location on the phantom for a period of two weeks after intake.  The key assumptions for 
this analysis include all external contamination has been removed/decontaminated, only 
one isotope has been used in the RDD and the suspect isotope is known.   
Based on medical guidance for commanders taken from the military handbook, 
Medical Management of Radiological Casualties [6], a Command Decision Level (CDL) 
was established to determine a threshold dose at which personnel would require further 
dosimetric evaluation.  For the analysis, the CDL was set to 25 cGy.  At this dose, 
expedited evacuation from theater would be considered based on commander’s 
operational guidance.   
Similar studies were conducted at Georgia Tech using commercial off-the-shelf 
radiation detectors and were directed at internal radiation exposure from an RDD to the 
general public.  These studies involved using a Geiger-Mueller-based detector by Manger 








 Radiological dispersal devices (RDDs) “are devices, other than a nuclear 
explosives device designed to disseminate radioactive material in order to cause 
destruction, damage, or injury” [11].  One type of RDD, commonly called a “dirty 
bomb,” uses conventional explosives to disperse radioactive contamination.  Dirty bombs 
can produce immediate casualties from the effects of the conventional explosion 
including blast injuries and trauma.  These effects were not considered in this analysis.  
In general, RDDs scatter radiological material creating a large area of contamination.  
The dose and dose rate are dependent on the type and amount of radioactive material 
used, which may not necessarily be uniformly distributed over the area.  An RDD may 
serve as an area denial weapon, posing a danger of external and internal radiological 
contamination [12].  Although external contamination may be removed by surface 
cleaning and removing contaminated clothing, internal contamination is more difficult to 
remove.  When the contaminants are ingested and/or inhaled, a high intensity prolonged 
radiation exposure may occur. 
 Over the past few decades, there has been an increase in the threat of use of 
Weapons of Mass Destruction (WMD).  Several small scale attacks over the past 20 years 
utilized biological and chemical agents.  Although there are no accounts of the true use of 
an RDD, the potential clearly exists.  In Chechnya, there were two cases of potential dirty 
bombs containing 
137
Cs.  In November 1995, a group of Chechen separatists buried a 
137
Cs source wrapped in explosives at the Izmaylovsky Park in Moscow.  A group of 
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Chechen rebels contacted a Russian television station and reported their ability to 
construct a radioactive bomb.  Neither the Chechens who planted the 
137
Cs, nor the origin 
of the source, were ever identified.  In December 1998, the Russian-backed Chechen 
Security Service announced that a team had found a container filled with 
137
Cs attached 
to an explosive mine hidden near a railway line.  The Security Service was able to safely 
defuse the bomb [13].  
 Radiation sources are used extensively in industrial and medical applications.  
Worldwide, accountability of these sources is poor.   Numerous radioactive materials 
have gone missing and are unaccounted for, many from Former Soviet Union (FSU) 
nations.  In addition to former weapons programs, radioactive sources obtained from 
laboratories, medical facilities, and industry, also have the potential for use in a RDD.   
 In Iraq and Afghanistan, there have been numerous reports of attacks on coalition 
forces in the form of small arms fire, improvised explosive devices (IEDs), as well as 
mortar and rocket attacks.  There have been instances of radioactive sources being 
reported to coalition forces in Iraq, albeit mostly low levels of radiation.  These isotopes 
could potentially be used in IEDs to produce an RDD to attack US and coalition forces.   
 Immediately after an IED attack, military forces secure the area unless otherwise 
dictated by the security of the area or the current mission.  An explosive ordnance 
disposal (EOD) team may conduct a post blast assessment, often identifying the materials 
used in an attack.  The EOD team is equipped with a military radiac detector, either an 
AN/VDR-2 or and AN/PDR-77 [14].  If significant levels of radiation are detected, the 
unit would also need to identify personnel who have received contamination.  
Decontamination procedures would then be conducted to remove external contamination.  
Management and treatment of internal contamination is more complex, requiring the need 
to identify personnel who have been contaminated.  Triaging must be conducted in order 
to identify and treat these individuals.  The ability to triage personnel in combat areas is 
limited due to the lack of resources readily available.   
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 One method to assess casualties is through the use of gamma cameras, which are 
capable of assessing the activity of a known isotope inhaled by an individual when the 
time and duration of exposure are known [15].  Previously conducted research using 
anthropomorphic phantoms evaluated the response of a gamma camera with five isotopes 
distributed in the lungs [16].  Due to their size, and inability to readily transport them on 
short notice, it would not be feasible to utilize these instruments in the event of an RDD 
in a combat environment.  
 A Whole Body Counter (WBC), such as the one used to identify casualties 
following the 
137
Cs accident in Goiania, Brazil, is another piece of equipment that may be 
used [17].  As with the gamma camera, this is also a large and complicated piece of 
equipment.  Furthermore, WBCs are not available for use in a combat environment, 
therefore other triage alternatives need to be evaluated.  
 Nearly all deployable Army units are equipped with radiation detection 
equipment, including the AN/VDR-2.  This instrument is ideal to measure radiation 
within Army units, as it has been widely fielded and operator-level training is mandatory.  
The present research provides a method for using this instrument to triage soldiers who 
have received internal contamination from isotopes producing high-energy gamma 
radiation, in an effort to identify soldiers requiring further dosimetric evaluation.     
 A methodology to categorize radioactive isotopes was developed by the Armed 
Forces Radiobiology Research Institute (AFRRI).  Using this schema, radioactive 
isotopes fall under the following categories: university seven, military four, fission 














Cf.  These sources are often used in medicine and isotropic labeling in 








Am, and are primarily 
used in the nuclear weapons complex.  Fission products are a result of a fission event (i.e. 
a weapon detonation), and have the potential for a significant risk to the public.  Finally, 













Co are used in widely industry for their penetrating gamma rays.  
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 The detonation of IEDs is a daily experience for some combat units in both Iraq 
and Afghanistan.  IEDs are made from a wide variety of materials and explosives.  The 
common procedures for reacting to an IED include assessing and treating casualties, 
securing the area, and reporting the contact to the higher command.  Unless there is a 
major security threat in the area, or the mission dictates that the convoy should continue 
movement, the unit will remain on site.  An Explosive Ordnance Disposal (EOD) team 
will often conduct a post blast analysis of the site.   During this assessment, the EOD 
team will use an AN/VDR-2 or AN/PDR-77 radiac detector to identify any potential 
radiological contamination.  The team will collect shrapnel and remnants of the IED and 
assess any damage caused to the surrounding area, including assessing the size of the 
crater produced, in an effort to identify the amount of materials used.  Although the EOD 
team would be able to detect contamination on site, they do not have the capability to 
identify the isotope [14].  In order to identify the isotope, a CBRNE (Chemical, 
Biological, Radiological, Nuclear, and high-yield Explosive) response team would 
respond to the site to analyze the sample.  The team would use a DTECH Rad-ID isotope 
identifier to obtain spectra from the sample to analyze the energy levels of particles 
emitted from the sample.  The spectral results are then sent to Department of Energy 
(DOE) Laboratories to verify the isotope present.  Depending on the location of the RDD 
and the response time from DOE, it would take approximately six hours from the time the 
EOD team detected radiation to identification of the sample [18]. 
 In a combat situation, an RDD could easily be mistaken for a simple poorly-made 
IED.  The device may have resulted in minimal damage and minimal initial casualties.  
Although soldiers may not have received any external wounds from the detonation of the 
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device, they could be receiving radiation through absorption, ingestion and inhalation.  
While securing the area and waiting for EOD to complete the investigation of the site, the 
soldiers would continuously be inhaling a radioactive source.   
 There have been no events involving the use of radioactive material in an IED, 
nor has there been any open source intelligence identifying insurgents intending to use 
radioactive material to produce an RDD.  However, if radioactive materials are 
employed, soldiers would be ill prepared to respond to such a threat.  In the event that the 
EOD team had discovered radioactive material during their post blast assessment, or 
soldiers started exhibiting symptoms of exposure to radiation, there would be a need to 
triage soldiers who may have been affected, and treat accordingly. 
 The military publication FM 4-02.283, Treatment of Nuclear and Radiological 
Casualties, is a guide for military medical personnel to recognize and treat nuclear and 
radiological casualties.  The manual applies to the nuclear battlefield and other operations 
where radiation hazards exist.  In order to estimate the radiological dose received, there 
are several different methods outlined.  The approximate severity of exposure can be 
estimated based on symptoms and their onset as seen in Table 2.1.1 [19].   
 





 Estimating radiation dose based on clinical symptoms has limited accuracy.  In 
addition, personnel may exhibit these symptoms under other battlefield or medical 
conditions including dehydration and food poisoning, which are more likely to occur in a 
foreign and arid environment.  Medical assays can also be used to determine the severity 
of the exposure.  There are a variety of these tests that can be performed at the 




Table 2.1.2 Medical Assay of the Radiological Patient 
 
  
 Currently, there is no capability to analyze bioassays within Iraq and Afghanistan.  
As a result, any samples obtained would need to be evacuated out of theater to determine 
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if soldiers require additional dosimetric evaluation.  This process would be extremely 
time consuming, and would result in delaying treatment.  The Army does possess gamma 
cameras that are available in Germany, but not deployed in the Middle East.  Personnel 
suspected of receiving contamination would need to be evacuated in order to utilize a 
gamma camera to assess the dose received [20].  By using a piece of equipment widely 
available to all units, triaging and identification of soldiers requiring any treatment and 
follow-on evaluation can be a local and less time-consuming process.  Overall, a 
sustainment of a commander’s combat power would be possible.   
 In addition to use in combat zones, the methodology developed in this study could 
also be used to assist military units which are responding to a domestic event.  National 
Guard units contain WMD-CSTs (Weapons of Mass Destruction Civil Support Teams) 
which provide support to domestic CBRNE consequence management events.  The teams 
are military first responders and advise civilian first responders regarding appropriate 
medical and technical advice.  These teams may also be deployed as an element of a 
response task force in support of the Lead Federal Agency [21].  
 For example, the 4
th
 WMD CST, based at Dobbins Air Force Base in Marietta, 
Georgia, provides support within the state of Georgia.  The team consists of 22 personnel, 
including a physician assistant, an environmental science officer, and a medical 
operations officer.  The team possesses both civilian and military radiac equipment 
including two AN/VDR-2s and three AN/PDR-77s.  When assessing an area that is a 
potential radiological hazard, personnel are required to wear personnel monitoring 
devices including thermoluminescent dosimeters (TLD) and direct reading pocket 
dosimeters.   Bioassays may also be obtained to monitor for deposited radioactive 
materials [22].  In the event of an RDD and radiological exposure, the CST would work 
to provide decontamination support and care for soldiers on the team.  The physician 
assistant would treat a soldier based on symptoms of radiological exposure, and follow-
up with bioassays.  Unless exposed personnel possessed a monitoring device at the time 
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of the incident (which is not always possible), they would need to wait until the results 
from the bioassay were returned in order to determine the extent of radiological exposure.  
By utilizing the military radiac equipment within the unit, the CST would be able to assist 








 The AN/VDR-2 and AN/PDR-77 use an identical handheld probe, the DT-616, 
which was modeled using MCNP.   The DT-616 probe model was used in conjunction 
with a PMMA slab phantom model using MCNP to verify the detector model.  The 
model was validated using experimental data obtained using the probe and radioactive 
sources in a laboratory.  Upon verification of the detector model, the detector model was 
placed in two MIRD phantom models representing the military population.  Simulations 






Ir distributed throughout various organs.  
The results from MCNP were used in conjunction with DCAL and International 
Commission on Radiological Protection (ICRP) dose coefficients to estimate the reading 
obtained using the detector that would indicate a person was exposed to a dose of 25 cGy 
of internal contamination.  These values were incorporated into triage procedure sheets 
which may be used by military personnel to triage those who may have inhaled the 

































































3.2 AN/VDR-2 and AN/PDR-77 Military Radiac Detectors 
 
 The AN/PDR-77 and the AN/VDR-2 are radiac detectors currently utilized by the 
Army and Marine Corps.  Both detectors have the capability to measure dose and dose 
rate for beta and gamma radiation.  The AN/VDR-2 is a standard piece of equipment 
common to nearly all deployable units.  The AN/PDR-77 is used primarily by EOD, 
ordnance and CBRNE units for nuclear accident and incident response.  In addition, each 
Army installation is issued two AN/PDR-77s to use to respond to radiological and 
nuclear incidents [24].   
 The AN/VDR-2 is one of the primary pieces of radiation detection equipment 
issued to most deployable units in the Army.  In order to determine the quantity of these 
instruments fielded in the Army, a Modified Table of Organization & Equipment 
(MTOE) was studied.  An MTOE is a document which authorizes units a specific number 
of personnel and equipment.  A typical infantry battalion consisting of over 600 soldiers 
is authorized from 40 to 60 AN/VDR-2s.  A medical company consisting of 
approximately 80 soldiers, which may be involved in the triaging and treatment of 
casualties, is authorized between 3 and 13 AN/VDR-2s.  Depending on the type of unit 
and their mission, deployable Army units typically possess one AN/VDR-2 for every 8-
25 soldiers [25].  Due to its vast availability, the AN/VDR-2 has the most potential for 
identifying radiological casualties on the battlefield. 
 The AN/VDR-2 military radiac detector was originally manufactured by Nuclear 
Research Corporation which was purchased by Canberra in the mid 1990s [1].  The 
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detector was designed for tactical and non-tactical protection use.  It has been engineered 
for use in extreme temperature conditions and highly elevated levels of radiation resulting 
from a nuclear accident or incident.  The AN/VDR-2 can be mounted on land vehicles 
and helicopters as well being operated by a foot soldier [26].   
 
 
Figure 3.2.1 AN/VDR-2 Radiac Detector 
 
 The AN/VDR-2 consists of an IM-243 radiacmeter and a DT-616 probe as shown 
in Figure 3.2.1.  Gamma radiation can be detected and measured at dose rates ranging 
from 0.01 μGy/hr to 100 Gy/hr.  Beta radiation can be detected at dose rates ranging from 
0.01 μGy/hr to 5 cGy/hr.  The device can also measure an accumulated dose ranging from 
0.01 μGy to 9.99 Gy.  The LCD display on the radiacmeter shows readings to three digit 
accuracy and the range is displayed in units of μGy/hr, cGy/hr, and Gy/hr, and μGy, cGy 
and Gy for total dose.  According to the Technical Manual (TM) for the AN/VDR-2, the 
14 
 
accuracy of the dose rate is ±20 percent for up to 10.0 Gy/hr and ±25 percent for up to 
100 Gy/hr (overall system error) [26]. 
 The DT-616 probe contains two Geiger-Mueller (GM) tubes.  The low range 
detector covers the range from 0.01 μGy/hr to 5 cGy/hr, and the high range detector 
covers the range from 2cGy/hr to 100 Gy/hr.  The low range tube is capable of detecting 
both gamma and beta radiation, whereas the high range tube is only capable of detecting 
gamma radiation.  The AN/VDR-2 contains a beta shield which covers the low range GM 
tube, resulting in the measurement of only gamma radiation.  Both tubes are energy 
compensated to provide a tissue dose response, with a roll-off below 100 keV to around 
50% at 50 keV and a relatively flat response from 100 keV to above 1 MeV.  During 
development, testing was conducted by the manufacturer using a 
137
Cs and a 
60
Co source, 
and x-rays of various energies produced by a filtered x-ray machine resulting in the 
relative response in Figure 3.2.2 [2, 24]. 
  
         
Figure 3.2.2 Relative Energy Response of the AN/VDR-2  
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 Geiger-Mueller counters are common radiation detectors, which have advantages 
over other detectors due to their simplicity, low cost and ease of operation.  
Disadvantages of these detectors include their inability to provide energy information and 
large amount of dead time, particularly in areas with high levels of radiation.  A thorough 
review of GM-based detection can be found in Knoll [27].  Due to the construction and 
shielding of the GM tubes in the DT-616, the detector attempts to provide a tissue dose 
response.  The DT-616 is able to operate in environments with high levels of radiation 
without missing events in dead time by using the “time-to-count” method.  The DT-616 
probe was also designed for operation in extreme temperatures by the selection of fill 
gases.  These three improvements make the detector suitable for military operations and 
usage [1]. 
 The GM tubes are operated in time-to-count mode.  This method was developed 
and patented by Jack Cooley and Elmo DiIanni [28].  This mode reduces the amount of 
dead time within the detector where a typical GM tube requires a longer recovery time 
between events.  In the time-to-count mode, the GM tube is operated at 250 volts, which 
is half the potential operating region.  In the count mode, the voltage is increased to 500 
volts, and an oscillator clock starts counting in 1 microsecond cycles.  The counting 
continues until a GM tube pulse is obtained, at which time, the time counting is stopped 
and the time is recorded.  At this point, the voltage is returned to half the operating 
voltage allowing the GM tube time to recover.  After two milliseconds, the GM tube is 
recovered and returns to the operating voltage.  During the count time, only one GM 
pulse can be obtained and the time is inversely proportional to the count rate.  This 
process occurs many times per second in order to obtain a statistically reliable time-to-
16 
 
count.  The sensitivity in the low range tube is approximately 30 cps/mR/hr and in the 
high range tube, the sensitivity is approximately 0.08 cps/mR/hr.  For low count rates, 
counting statistics are not ideal, requiring long count times to obtain accurate results [1].   
   The modeling was conducted for the DT-616 probe of the AN/VDR-2.  This 
probe is also a component of the AN/PDR-77 radiac set.  Due to its limited fielding, the 
AN/PDR-77 is not as readily available in combat zones compared to the AN/VDR-2.  
The AN/PDR-77 uses an IM-263 radiacmeter as opposed to the IM-243 radiacmeter used 
with the AN/VDR-2.    In order to reduce development time, the IM-263 was modeled 
after the IM-243, and operates similar to the IM-243.  The IM-263 has improvements 
over the IM-243 including the ability to subtract background radiation.  In addition to the 
DT-616 probe, the AN/PDR-77 also contains a DT-669 alpha probe, and a DT-674 x-ray 
probe as shown in Figure 3.2.3.  The AN/PDR-77 measures beta and gamma radiation in 
Rad/hr, as opposed to the AN/VDR-2 measuring in Gray/hr [29].  In addition to being 
widely used by the Army and Marine Corps, the DT-616 probe is a component of radiac 
detectors utilized by other NATO nations.  Canada, Italy and Great Britain also use radiac 
detectors containing a DT-616 probe and radiacmeters modeled after the IM-243 [1].         
 




Figure 3.2.3 AN/PDR-77 Radiac Detector  
 
 The DT-616 probe from the AN/VDR-2 and AN/PDR-77 radiac detectors was 
modeled using MCNP and VisEd [30].  Detailed drawings (Figure 3.2.4) and 
specifications of the probe were obtained directly from Canberra [1].  The internal 
components of the probe are shown in Figure 3.2.5.  The modeling effort focused only on 
the GM tubes and associated shielding.  The electronics were not modeled as their effect 
was insignificant for this analysis and would be compensated for in the detector scaling 
factors.  Material densities and compositions were obtained from the Standards 
Compositions Manual [31] and Rad Toolbox [32].  The composition of the aluminum 
alloy was obtained using North American Die Casting Association product specification 





Figure 3.2.4 Technical Drawing of DT-616 Probe 
 
 
Figure 3.2.5 Internal Components of DT-616 Probe (High-Range Tube is not shown) 
 
 
Figure 3.2.6 VisEd Representation of DT-616 Probe 
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3.3  PMMA Slab Phantom Measurements 
 
 In order to validate the computational model of the detector, a PMMA slab 
phantom was used to conduct benchmark measurements with the DT-616.  The slab 
phantom consisted of varying thicknesses of PMMA ranging from 0 cm to 3 cm in 
increments of 0.6 cm.  A source holder constructed of PMMA was used to secure the 
source and virtual water was placed behind the source holder as a backscatter medium.  
Virtual water was obtained from the CNMC Company and is designed to scatter and 
attenuate photons in the same manner as water.  Virtual water is commonly used for 
quality assurance and validation of medical radiation treatment plans [34].  Four different 








Na.  Information on the 
sources used is located in Table 3.3.1.  These sources were chosen due to the broad range 




Cs are considered 
military significant candidate RDD isotopes and were also used with the MIRD 
phantoms.  
 
Table 3.3.1 Source Activity 











Co 27 FEB 07 10,000 2.72E+2 19 FEB 10 580.559 
60
Co 19 MAR 02 10 1.92E+3 19 FEB 10 3.524 
137
Cs 28 FEB 92 10 1.10E+4 11 MAR 10 6.608 
22
Na 17 JUL 09 1 9.51E+02 03 MAR 10 0.818 
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Table 3.3.2 Gamma Energy Intensity Data 
Isotope Energy (keV) Intensity 
57
Co 122, 6.4, 6.39, 136, 14.4, 
7.06, 7.06, 0.705, 692 
0.856, 0.334, 0.169, 0.106, 0.092, 
0.045, 0.029, 0.0026, 0.0016 
60
Co 1173, 1333 0.9985, 0.9998 
137
Cs 662 0.898 
22
Na 511, 1270 1.8, 0.999 
  
 For the experimental set-up (Figure 3.3.1), the DT-616 was placed one inch from 
the PMMA slab in all of the measurements.  The dose rates were recorded five times for 
each thickness of the PMMA slab for each isotope to ensure consistency for each run, and 
a total of three runs were conducted for each isotope and thickness.   The background was 
obtained by taking the average over 20 readings in the absence of the sources.    An 
average was taken of the dose rates for each thickness of PMMA for each source, and the 
background radiation was subtracted.  Results showing the attenuation of 
60
Co are shown 






Figure 3.2.1 Experimental Set-up 
 
 




















3.4  MCNP Model Verification 
 
 A slab phantom model was created using MCNP.   The slab phantom consisted of 
virtual water, air, a source holder, and PMMA.  A separate slab phantom was created for 
each of the varying thicknesses of PMMA ranging from 0 cm to 3 cm.  A representation 
of the model using VisEd is shown in Figure 3.4.1 for a model consisting of 3 cm of 
PMMA.  The composition for these materials is in Table 3.4.1. 
 
 













PMMA Slabs and Source 
Holder 
H                 8.06%                                   
C                 59.99%                                 
O                 31.95% 
1.19
Virtual Water H                 0.64%                                 
C                 63.99%                                 
N                 2.53%                                 
O                 25.14%                                 
Cl                0.39%l                                 
Ca               7.31% 
1.03
Surrounding Air N                76.5058%                        
O                23.4793%                          





 A track length estimate of cell flux (F4 tally) was generated using MCNP over the 
volume of the GM tube in the DT-616 [2].  The tally output was distributed over 19 
energy bins.  The MCNP computed flux for each energy bin was folded with the ICRP-74 
conversion factor (H*(10)/Φ) [35] and the source strength used in the laboratory analysis, 
to obtain the ambient dose equivalent at each energy bin.  The ambient dose equivalents 
for each bin were summed to obtain the total dose rate.  This calculated dose rate was 
divided by the experimental dose rate to obtain a scaling factor for each of the four 






3.5  MIRD Computational Phantoms and Biokinetics 
 
 Since the military has standards for physical fitness and age, the primary people 
of concern would be of a greater level of physical fitness than the general population, 
thus only the reference male and reference female anthropomorphic computational 
phantoms were studied.  Both of these are MIRD phantoms, initially developed at Oak 
Ridge National Laboratory (ORNL) [3].  Pacific Northwest National Laboratory created 
MCNP-coded versions of the MIRD phantoms using ICRP 32 recommendations [36, 37]. 
The phantoms were further modified at Georgia Institute of Technology with the addition 




Table 3.5.1 MIRD Phantoms 
Body Type Height (cm) Weight (kg) BMI  
Reference Male 179 73.1 23 
Reference Female 168 56.5 20 
 
 Four detector locations were selected of the study of the reference male; the 
anterior right upper torso, the posterior right upper torso, the anterior of the neck, and the 
lateral left thigh.  For the reference female, the anterior right upper torso was not used 
due to the attenuation from breast tissue.  The two upper torso positions were used due to 
the inhalation initially depositing the isotope within the lungs.  As a result, a higher dose 
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rate would be initially acquired by taking measurements over the lungs.  Due to the 
location of the heart on the left side of the body, a higher count rate is obtained by using 
the right lung.  The neck was selected to obtain counts from any isotopes that are thyroid 
seekers.   






Ir, since all three isotopes can be detected by an AN/VDR-2 and AN/PDR-77 and are 
also militarily significant candidate isotopes for RDDs.  DCAL was used to provide the 
distribution of each of the three isotopes within the body over a given period of time.   
The sources were distributed based on organs where the isotopes would migrate to 
according to DCAL, as seen in Table 3.5.2. 
 








Blood X X X 
Body Tissue X X X 
Kidneys   X 
Liver X  X 
Lower Large 
Intestines Contents 
X X X 
Lungs X X X 
Small Intestines 
Contents 
X X X 
Spleen   X 
Stomach Contents X X X 
Upper Large 
Intestines Contents 
X X X 
Urinary Bladder 
Contents 
X X X 
   
26 
 
 The dose rate at four locations was simulated using MCNP to determine the 
optimum location to obtain a dose during triage.  Since the isotopes are inhaled, the dose 
is initially greatest in the lungs.  Detectors were placed on the model one inch away from 
the surface as shown in Figure 3.5.1.  The distance of one inch was selected based on 
personnel monitoring procedures outlined by the Army [39].  Although this methodology 
assumes that external contamination was removed, ensuring the probe does not touch the 
person prevents the probe from getting contaminated.   
 
 
Figure 3.5.1 Detector Placement on the Anthropomorphic Phantoms 
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 A track length estimate of cell flux (F4 tally) was used in conjunction with a 
source contribution tally modifier (SCX card) to determine the flux in the detector per 
unit source distributed in each organ [2].  The tally modifier records the source organ of 
each particle reaching the detector.  The flux was then multiplied by the H*(10)/Φ 
coefficient to obtain the ambient dose equivalent contributed by each organ.  
 
 
3.6  DCAL Biokinetic Modeling 
 
 ORNL developed the DCAL code which calculates the tissue dose and 
subsequent health risks resulting from exposure or intake of isotopes.  DCAL can 
perform biokinetic and dosimetric calculations for the uptake of an isotope, by the 
pathways of inhalation, ingestion and injection.  The dose rates can be computed as a 
function of time following the intake of the isotope.  DCAL contains extensive libraries 
of biokinetic data, dosimetric data, and models to provide the most accurate estimate of 
the behavior of the isotopes within the body [5].  






Ir over a 
period of time following the release of radioactive material from an RDD.  The inhalation 
from an environmental source was selected as the pathway on DCAL.  In this pathway, 
the isotopes are initially deposited in the lungs, and are transported to different organs in 
the body based on their chemical properties.  ICRP default inhalation classes were used 




Ir set to moderate absorption and 
137
Cs set to 
fast absorption [40].  
137
Cs was also analyzed using a moderate inhalation class.  The 
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diameter of the particles was set to the default of 1 μm.  DCAL was used to estimate the 
amount of each isotope in the body over a period of 30 days.   Figures 3.6.1-3.6.4 
illustrate the amount of the isotopes in the major organs where the various isotopes 
migrate.  
137




Ir are both transition metals with similar chemical properties and tend to migrate from 
the lungs to the stomach and intestines.  
  
 
Figure 3.6.1 Distribution of 
137


















































Figure 3.6.2 Distribution of 
137





Figure 3.6.3 Distribution of 
60




























































































Figure 3.6.4 Distribution of 
192
Ir in Male Phantom 
 
  
 According to DCAL, more than half of the inhaled initial activity of isotopes with 









Ir have nearly the same removal time from the body, whereas 
the body retains 
137
Cs at significantly higher concentrations, as shown in Figure 3.5.4.  
Using a moderate inhalation class for 
137





















































Figure 3.6.5 Retention of Isotopes in the Body 
 
3.7 Command Decision Levels and Triaging Protocol 
 
 Upon completion of running the phantom models in MCNP, a dose rate per unit 
activity was determined.  Based on commander’s guidance in Medical Management for 
Radiological Casualties [6], a Command Decision Level (CDL) was established at which 
personnel would require additional dosimetric evaluation with the possibility for 
expedited evacuation from theater.  The CDL was selected at 25 cGy.  Using the DT-616 
probe, readings would be taken at locations that produce the highest dose rate from the 
MIRD phantom model.  A triage procedure sheet for military personnel provides 
information for AN/VDR-2 and AN/PDR-77 equipment operators to properly assess 
































4.1  Model Validation and Scaling Factors 
 
 In order to determine scaling factors and validate the model, the response from the 
detector in the laboratory was compared to the MCNP detector model.  According to Jack 
Cooley, who was responsible for the engineering and development of the probe, the 
probe was designed to provide a tissue dose response with a roll-off around 100 keV [1].  
Four different isotopes were measured using the DT-616 probe.  Isotopes were selected to 
provide a range of energies for gamma-ray emission.  Using the F4 tally on MCNP to 
compare ambient dose equivalent, a dose rate in units of picoSievert per second was 
obtained.  This value was divided by the experimental response of the detector which was 
converted to picoSievert per second.  The ratios of these values are shown in Figures 
4.1.1 through 4.1.4.  These ratios remain relatively constant over various PMMA 
thicknesses for each isotope.  These results provide confidence in using the detector 



































































































































 Errors bar on the graphs represent a five percent fluctuation in both directions 
based on the readings of the detector.  The detector takes an average of the time to count 
data over a period of two seconds.  During the experimental measurements, the readings 
provided by the detector fluctuated within a ten percent range.  Applying this factor of ten 
percent is reasonable according to Canberra [1].  The scaling factor for each of the 
isotopes was obtained by taking the average values of the calculated/experimental data.  
The scaling factor was plotted against the average photon energy of the isotope in Figure 
4.1.5.  Based on the dose response of the detector, a trend line was added as a log 
function to show the relationship between the energy and scaling factor. 
 
 
Figure 4.1.5 Scaling Factors vs. Average Photon 
 


















Cs is the isotope most commonly used by the Army to calibrate the radiac 
meter [24].  Therefore, the response of the detector for each isotope was normalized to 
provide the relative energy response with respect to 
137
Cs.    These data are shown in 
Figure 4.1.6. 
 




4.2  MIRD Phantom Results 
 
 An SCX tally modifier was used to generate a unit source in each organ and   
show the contribution of each organ to the detector reading at each location.  It does not 
show the actual distribution of the isotope.  Figures 4.2.1-4.2.3 show the contribution 
from each organ to the readings on the detector after the scaling factors have been 
applied.  Units are displayed in picoSievert/second per becquerel.  Initially, all of the 








































results are shown for 12 hours after exposure, at which time the isotopes are able to 
migrate within the body. This is also a reasonable time for deployed military forces to 
detect the radiation, identify the isotope, and begin triage procedures.    
 Figure 4.2.1 illustrates that after 12 hours, nearly all of the 
137
Cs has migrated 
from the lungs to the body tissue when classified in the fast inhalation class.  The activity 
in the body tissue was distributed uniformly to all regions that were not compartments in 
the DCAL model, which includes the legs and areas in the torso not occupied by organs.   
This contribution from the body tissue results in nearly all of the activity detected by the 
DT-616 probe.   When classified in the moderate inhalation class, the majority of activity 
read by the detector from 
137
Cs still originates in the lungs, but with a large amount 
coming from body tissue as shown in Figure 4.2.2 
 








































 Figures 4.2.3 and 4.2.4 illustrate the organs contributing to the detector readings 




Ir.  For both of these isotopes, the majority of the reading is 




































































































 The estimated radiac dose rate reading using an AN/VDR-2 or AN/PDR-77 was 
calculated with the output of the MCNP file.  Using the SCX tally, the ambient dose 
equivalent was calculated for significant organs for each detector location.  This data was 
folded with the biokinetic information provided using DCAL to obtain the contribution of 
each organ to the reading of the detector.  The result was summed to determine the 
expected detector reading from one becquerel of activity from the isotope.  The results 




Co and Ir-92 are in Tables 4.2.1-
4.2.4.  The estimated radiac dose rate reading per becquerel for the female phantoms is 
located in Appendix A. 
 








Time Back Right Lung Front Right Lung Neck Thigh
(Days) μGy/hr per Bq μGy/hr per Bq μGy/hr per Bq μGy/hr per Bq
0 7.05E-08 6.49E-08 1.33E-08 1.86E-10
0.5 2.72E-07 2.90E-07 1.61E-07 1.06E-07
1 3.09E-07 3.31E-07 1.93E-07 1.28E-07
2 3.06E-07 3.29E-07 1.96E-07 1.32E-07
3 2.97E-07 3.20E-07 1.91E-07 1.29E-07
4 2.90E-07 3.12E-07 1.88E-07 1.27E-07
5 2.85E-07 3.07E-07 1.85E-07 1.25E-07
6 2.81E-07 3.03E-07 1.82E-07 1.23E-07
7 2.78E-07 3.00E-07 1.80E-07 1.22E-07
8 2.75E-07 2.97E-07 1.78E-07 1.21E-07
9 2.73E-07 2.94E-07 1.77E-07 1.20E-07
10 2.71E-07 2.92E-07 1.76E-07 1.19E-07
12 2.67E-07 2.87E-07 1.73E-07 1.17E-07
14 2.63E-07 2.83E-07 1.71E-07 1.15E-07
20 2.53E-07 2.73E-07 1.64E-07 1.11E-07






























Time Back Right Lung Front Right Lung Neck Thigh
(Days) μGy/hr per Bq μGy/hr per Bq μGy/hr per Bq μGy/hr per Bq
0 7.05E-08 6.49E-08 1.33E-08 1.86E-10
0.5 9.28E-08 9.21E-08 3.01E-08 1.58E-08
1 8.87E-08 8.87E-08 3.38E-08 2.05E-08
2 7.91E-08 7.94E-08 3.33E-08 2.01E-08
3 7.44E-08 7.48E-08 3.24E-08 1.87E-08
4 7.23E-08 7.28E-08 3.20E-08 1.80E-08
5 7.13E-08 7.19E-08 3.18E-08 1.78E-08
6 7.07E-08 7.13E-08 3.17E-08 1.77E-08
7 7.03E-08 7.10E-08 3.17E-08 1.77E-08
8 7.00E-08 7.08E-08 3.17E-08 1.77E-08
9 6.98E-08 7.06E-08 3.17E-08 1.78E-08
10 6.96E-08 7.05E-08 3.18E-08 1.79E-08
12 6.93E-08 7.02E-08 3.19E-08 1.81E-08
14 6.90E-08 7.00E-08 3.20E-08 1.82E-08
20 6.81E-08 6.94E-08 3.24E-08 1.87E-08















Time Back Right Lung Front Right Lung Neck Thigh
(Days) μGy/hr per Bq μGy/hr per Bq μGy/hr per Bq μGy/hr per Bq
0 2.91E-07 2.69E-07 2.69E-07 6.20E-08
0.5 1.65E-07 1.43E-07 1.61E-07 3.16E-08
1 1.44E-07 1.15E-07 1.41E-07 2.62E-08
2 1.21E-07 8.78E-08 1.18E-07 2.08E-08
3 1.10E-07 7.78E-08 1.08E-07 1.86E-08
4 1.05E-07 7.37E-08 1.02E-07 1.77E-08
5 1.01E-07 7.18E-08 9.86E-08 1.72E-08
6 9.84E-08 7.06E-08 9.58E-08 1.70E-08
7 9.62E-08 6.98E-08 9.36E-08 1.67E-08
8 9.42E-08 6.90E-08 9.15E-08 1.65E-08
9 9.23E-08 6.84E-08 8.97E-08 1.64E-08
10 9.06E-08 6.77E-08 8.80E-08 1.62E-08
12 8.76E-08 6.65E-08 8.50E-08 1.59E-08
14 8.49E-08 6.53E-08 8.23E-08 1.56E-08
20 7.85E-08 6.22E-08 7.61E-08 1.48E-08






















 The percentage error for the analysis conducted using MNCP was calculated for 
each organ using the SCX tally modifier card.  The error was averaged over all organs for 
each detector location and isotope.  The overall error for all detectors and isotopes was 
approximately 1.7%.  The error was the lowest for detectors placed over the anterior right 
lung and posterior right lung, which averaged below 1%.  The error was highest for the 
detector placed on the left thigh, which averaged around 3%.  
 
 
4.3  Phantom Isotope Decision Levels 
 
 The estimated reading above the background of each detector location for a given 
isotope at the CDL was calculated.  If the detector reading is above this level, it is 
recommended for the person to receive additional dosimetric evaluation.  In order to 
calculate the radiac dose rate reading which corresponds to one CDL, the radiac dose rate 
Time Back Right Lung Front Right Lung Neck Thigh
(Days) μGy/hr per Bq μGy/hr per Bq μGy/hr per Bq μGy/hr per Bq
0 9.88E-08 9.12E-08 1.63E-08 1.41E-10
0.5 5.36E-08 5.23E-08 1.20E-08 4.98E-09
1 4.59E-08 4.46E-08 1.16E-08 6.16E-09
2 3.74E-08 3.63E-08 1.05E-08 5.38E-09
3 3.39E-08 3.30E-08 9.90E-09 4.52E-09
4 3.23E-08 3.15E-08 9.62E-09 4.10E-09
5 3.14E-08 3.06E-08 9.45E-09 3.92E-09
6 3.07E-08 3.00E-08 9.32E-09 3.84E-09
7 3.02E-08 2.95E-08 9.21E-09 3.80E-09
8 2.97E-08 2.90E-08 9.11E-09 3.78E-09
9 2.92E-08 2.85E-08 9.02E-09 3.77E-09
10 2.87E-08 2.81E-08 8.93E-09 3.75E-09
12 2.78E-08 2.73E-08 8.76E-09 3.73E-09
14 2.70E-08 2.65E-08 8.60E-09 3.71E-09
20 2.47E-08 2.43E-08 8.16E-09 3.64E-09

















reading per becquerel is multiplied by the number of becquerel per CDL.  The CDL, 
previously established at 25 cGy, was divided by the ICRP dose coefficient for each 
isotope to determine the number of becquerel per CDL.  For 
137
Cs, which was classified 
as a fast inhalation class, the dose coefficient used was 4.6 x 10
-07
 rem per becquerel.  As 
moderate inhalation class, the dose coefficient used was 9.7 x 10
-07




Ir were both considered as moderate inhalation class and dose coefficients 
used were 1 x 10
-06
 and 4.81 x 10
-07
 rem per becquerel, respectively.  Table 4.3.1 shows 
the expected readings for one CDL for a male with internal 
137
Cs contamination at a fast 
inhalation class using the AN/VDR-2.  The highest readings were obtained with detector 
placements at the lungs.  Table 4.3.2 shows the expected readings for 
137
Cs at a moderate 
inhalation class.   
 
Table 4.3.1 Radiac Dose Rate Reading per CDL for Male with 
137




Time Back Right Lung Front Right Lung Neck Thigh
(Days) μGy/hr per CDL μGy/hr per CDL μGy/hr per CDL μGy/hr per BCDL
Class → F F F F
0 3.83E+00 3.76E+00 7.72E-01 2.56E-02
0.5 1.58E+01 1.68E+01 9.36E+00 1.46E+01
1 1.79E+01 1.92E+01 1.12E+01 1.77E+01
2 1.78E+01 1.91E+01 1.14E+01 1.82E+01
3 1.72E+01 1.85E+01 1.11E+01 1.79E+01
4 1.68E+01 1.81E+01 1.09E+01 1.75E+01
5 1.65E+01 1.78E+01 1.07E+01 1.72E+01
6 1.63E+01 1.76E+01 1.06E+01 1.70E+01
7 1.61E+01 1.74E+01 1.05E+01 1.68E+01
8 1.60E+01 1.72E+01 1.04E+01 1.67E+01
9 1.58E+01 1.71E+01 1.03E+01 1.65E+01
10 1.57E+01 1.69E+01 1.02E+01 1.64E+01
12 1.55E+01 1.67E+01 1.00E+01 1.61E+01
14 1.53E+01 1.64E+01 9.89E+00 1.59E+01
20 1.47E+01 1.58E+01 9.51E+00 1.53E+01























 Tables 4.3.3 and 4.3.4 show the radiac dose rate readings obtained for one CDL of 




Ir using the AN/VDR-2.  For both of these isotopes, the 
highest readings are obtained with the detector placement at the posterior right lung.  
Similar results were obtained using the female phantoms.  The detector readings for the 
AN/PDR-77 for the male phantom and the detector readings for the AN/VDR-2 and 






Time Back Right Lung Front Right Lung Neck Thigh
(Days) μGy/hr per CDL μGy/hr per CDL μGy/hr per CDL μGy/hr per BCDL
Class → M M M M 
0 1.82E+00 1.14E+00 1.03E-02 6.78E-04
0.5 2.65E+00 9.09E-01 2.43E-01 2.39E-02
1 2.29E+00 8.96E-01 2.99E-01 2.96E-02
2 1.89E+00 8.23E-01 2.56E-01 2.59E-02
3 1.73E+00 7.83E-01 2.11E-01 2.17E-02
4 1.65E+00 7.63E-01 1.89E-01 1.97E-02
5 1.61E+00 7.51E-01 1.80E-01 1.88E-02
6 1.57E+00 7.42E-01 1.76E-01 1.85E-02
7 1.55E+00 7.34E-01 1.74E-01 1.83E-02
8 1.52E+00 7.27E-01 1.73E-01 1.82E-02
9 1.50E+00 7.20E-01 1.72E-01 1.81E-02
10 1.47E+00 7.13E-01 1.71E-01 1.80E-02
12 1.43E+00 7.01E-01 1.70E-01 1.79E-02
14 1.39E+00 6.89E-01 1.69E-01 1.78E-02
20 1.27E+00 6.57E-01 1.66E-01 1.75E-02

















Table 4.3.3 Radiac Dose Rate Reading per CDL for Male with 
60




Table 4.3.4 Radiac Dose Rate Reading per CDL for Male with 
192





Time Back Right Lung Front Right Lung Neck Thigh
(Days) μGy/hr per CDL μGy/hr per CDL μGy/hr per CDL μGy/hr per CDL
Class → M M M M
0 7.27E+00 6.72E+00 1.55E+00 4.67E-02
0.5 4.12E+00 4.03E+00 1.09E+00 5.14E-01
1 3.60E+00 3.52E+00 1.09E+00 6.50E-01
2 3.03E+00 2.95E+00 1.04E+00 6.02E-01
3 2.76E+00 2.69E+00 9.86E-01 5.12E-01
4 2.62E+00 2.55E+00 9.44E-01 4.55E-01
5 2.53E+00 2.46E+00 9.09E-01 4.21E-01
6 2.46E+00 2.40E+00 8.80E-01 3.99E-01
7 2.40E+00 2.34E+00 8.55E-01 3.83E-01
8 2.35E+00 2.29E+00 8.33E-01 3.69E-01
9 2.31E+00 2.24E+00 8.13E-01 3.58E-01
10 2.27E+00 2.20E+00 7.95E-01 3.47E-01
12 2.19E+00 2.12E+00 7.64E-01 3.31E-01
14 2.12E+00 2.06E+00 7.38E-01 3.18E-01
20 1.96E+00 1.90E+00 6.81E-01 2.93E-01















Time Back Right Lung Front Right Lung Neck Thigh
(Days) μGy/hr per CDL μGy/hr per CDL μGy/hr per CDL μGy/hr per CDL
Class → M M M M
0 4.75E+00 4.39E+00 7.84E-01 6.78E-03
0.5 2.58E+00 4.25E+00 5.77E-01 2.39E-01
1 2.20E+00 2.15E+00 5.57E-01 2.96E-01
2 1.80E+00 1.75E+00 5.03E-01 2.59E-01
3 1.63E+00 1.59E+00 4.76E-01 2.17E-01
4 1.55E+00 1.51E+00 4.62E-01 1.97E-01
5 1.51E+00 1.47E+00 4.54E-01 1.88E-01
6 1.48E+00 1.44E+00 4.48E-01 1.85E-01
7 1.45E+00 1.42E+00 4.43E-01 1.83E-01
8 1.43E+00 1.39E+00 4.38E-01 1.82E-01
9 1.40E+00 1.37E+00 4.34E-01 1.81E-01
10 1.38E+00 1.35E+00 4.29E-01 1.80E-01
12 1.34E+00 1.31E+00 4.21E-01 1.79E-01
14 1.30E+00 1.27E+00 4.14E-01 1.78E-01
20 1.19E+00 1.17E+00 3.93E-01 1.75E-01

















 A graphical comparison of the external dose rate readings as indicated by the 



























































































 For the three isotopes, the highest dose rate readings came from the posterior right 
lung.  Similar results were also found using the female phantoms.  For triage procedures, 
all readings should be taken using the posterior right lung.   




Ir, as the graphs have similar curves.  This can be attributed to the isotopes having 
similar chemical properties due to the number of valence electrons, and the same 
inhalation class.   The retention rate of 
192
Ir is slightly lower than that of 
60
Co which may 
be partially due to 
192
Ir having an effective  half-life of 74 days compared to that of 
60
Co 
which is at 5.27 years [32].  When factoring in the biological removal from the body, the 
effective half-life of 
192
Ir is slightly less than 
60
Co.  The external dose rate reading per 
CDL using the DT-616 for 
60

























per CDL for 
192
Ir.  This can be attributed to 
60
Co emitting higher energy gamma rays 
which are more likely to be detected by the DT-616 probe. 
 The radiac dose rate reading per CDL for 
137




Ir.  This can be attributed to several reasons.  
137
Cs is classified as “fast” 




Ir are both considered as “moderate” inhalation class.  
These classes are based on the International Commission of Radiological Protection 
(ICRP) defaults [40].  The dose coefficient for 
137
Cs is less than half of that for 
60
Co.  As 
a “fast” inhalation class, 
137
Cs tends to migrate away from the lungs at a faster rate than 
isotopes with a moderate class.  Since the 
137
Cs is deposited in body tissue as opposed to 
the lungs, it is closer to the surface of the body.  As a result, there is less attenuation of 
the gamma rays, resulting in a larger reading by the DT-616.  When 
137
Cs was treated as 
a moderate inhalation class, the radiac dose rate reading per CDL is approximately 12% 
of the radiac dose rate reading per CDL when treated as a fast inhalation class.  





 In determining the decision levels, one also needs to evaluate the “detection limit” 
of the counting system.  The minimum radiac dose rate reading above the background 
reading resulting in real activity must be determined.  The average background dose rate 
in the laboratory was 0.198 μGy/hr.  Since the detector uses GM tubes, the dose rate is 
actually a count rate.  Using the count rate per unit activity data obtained from Canberra 
(Figure 4.3.5), the background count rate was determined to be 35.8 cpm.    When the 
number of counts is over 30, the Central Limit Theorem applies, and both the mean of the 
net counts and sample counts should both follow a Normal distribution. 
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 False positives are the result of an increased reading on the detector when there is 
no real activity present.  Fluctuations could be due to counting statistics, and positive 
indications could actually be false positives.  In order to limit the false positives, the 
critical level, Lc should be set high enough to ensure a measure of statistical certainty.  To 
ensure false positives are no greater than 5%, the following equation should be used [27] 
  𝐿𝐶 = 1.645 𝜎𝑁𝑆 = 1.645 2 𝜎𝑁𝐵 = 2.326 𝜎𝐵             [Equation 4.3.1] 
Using equation 4.3.1, Lc is equal to 13.921 cpm.  Therefore any activity that is 13.92 cpm 
or 0.077 μGy/hr above the background may be considered to be real activity.  This value 
is significantly below the activity per CDL, making the detector readings following one 
week of exposure statistically significant. 
 
 






















4.4  Triage Procedure Sheets 
 
 In order for these results to be utilized by military personnel in the event of an 
RDD, triaging procedure sheets were developed.  The procedure sheets are for equipment 
operators to evaluate personnel and determine if further dosimetric evaluation is required.  
Separate procedure sheets were developed for the AN/VDR-2 and AN/PDR-77.  
Although there should be several trained operators to use each piece of equipment, the 
procedure sheets also include basic operation of the detectors.   In MCNP, the detector 
was placed one inch away from the surface of the phantom.  Additional files were also 
run using MCNP with the detector on the surface of the phantom.  The resulting dose rate 
per CDL was approximately 30% greater than when the detector was placed one inch 
away.  By using the lower number at one inch away, it provides a more conservative 
estimate.  Tables 4.4.1 and 4.4.2 indicate the expected dose rate reading for individuals 
who have inhaled one CDL of isotope.  
137
Cs was treated as a moderate inhalation class 
in order to obtain a more conservative reading.  These values reported are the same as 











Table 4.4.1 Radiac Dose Rate Reading per CDL using the AN/VDR-2 
 
 
Table 4.4.2 Radiac Dose Rate Reading per CDL using the AN/PDR-77 
  
Gender
Isotope 137Cs 60Co 192Ir 137Cs 60Co 192Ir
0 1.82 7.27 4.75 1.83 7.37 4.85
0.5 2.39 4.12 2.58 2.52 3.84 2.65
1 2.29 3.60 2.20 2.47 3.23 2.29
2 2.04 3.03 1.80 2.24 2.60 1.89
3 1.92 2.76 1.63 2.12 2.34 1.73
4 1.86 2.62 1.55 2.07 2.22 1.65
5 1.84 2.53 1.51 2.04 2.14 1.61
6 1.82 2.46 1.48 2.03 2.09 1.57
7 1.81 2.40 1.45 2.02 2.05 1.55
8 1.80 2.35 1.43 2.01 2.01 1.52
9 1.80 2.31 1.40 2.01 1.97 1.50















Readings are in μGy/hr per CDL
Male Female
Gender
Isotope 137Cs 60Co 192Ir 137Cs 60Co 192Ir
0 0.18 0.73 0.48 0.18 0.74 0.48
0.5 0.24 0.41 0.26 0.25 0.38 0.26
1 0.23 0.36 0.22 0.25 0.32 0.23
2 0.20 0.30 0.18 0.22 0.26 0.19
3 0.19 0.28 0.16 0.21 0.23 0.17
4 0.19 0.26 0.16 0.21 0.22 0.17
5 0.18 0.25 0.15 0.20 0.21 0.16
6 0.18 0.25 0.15 0.20 0.21 0.16
7 0.18 0.24 0.15 0.20 0.20 0.15
8 0.18 0.24 0.14 0.20 0.20 0.15
9 0.18 0.23 0.14 0.20 0.20 0.15






















 In the event of an RDD attack in a combat area, the AN/VDR-2 and AN/PDR-77 







Ir.  The minimum detectable activity (MDA) was determined to be 
0.077 μGy/hr above the background dose rate, which is insignificant compared to the 
radiac dose rate reading per CDL for each of the isotopes.  Inhalation classes and detector 
placement were selected to provide a conservative estimate of triage level, thus 
minimizing false negatives.  
  The AN/VDR-2 is widely available to combat units currently deployed to Iraq 
and Afghanistan, and will likely remain in the military inventory for the next decade.  
Although there is better technology available to detect internal contamination, including 
gamma cameras and the Whole Body Counter, these devices are not available to 
deployed units, and will not likely become available in the theater of operations until the 
use of RDDs becomes a common occurrence.   
 Both radiac sets are not able to detect isotopes with low energy gamma photons 
including Am-241 and Sr-90.  As a result, traditional methods to assess casualties, 
including the use of bioassays and determining the level of contamination based on 
clinical symptoms, will continue to be the only methods available to assess these 






 This study focused on the specific scenario of an RDD detonation in a combat 
environment evaluating three isotopes of interest to the military.  As a result it focused on 
one probe being used to evaluate an average male and female, which would be typical of 
the population of the military.   
 This research could be expanded by increasing the size of the population 
evaluated.  In order to triage civilians on the battlefield, including contractors working for 
US and allied forces and local nationals, additional phantoms would be needed to account 
for various body types.  Additionally, the AN/VDR-2 could also be used by military 
personnel to triage casualties in a domestic event involving an RDD. 
 Although there were only three isotopes considered in this research, there are 
several other isotopes identified by the Army, the Centers for Disease Control and 
Prevention, the DOE and Nuclear Regulatory Commission which are also of interest and 
could be studied further [6].    The DT-616 probe has a limited ability to detect low 
energy gamma radiation.    The IM-263 radiacmeter in the AN/PDR-77 kit can be used 
with eight different probes.  The DT-674 x-ray probe contains a 5” diameter x 0.25” thick 
NaI scintillation crystal and a 2” diameter PMT.  This probe is able to detect low energy 
photons at 17 keV with upper and lower discriminators set for 12.5 and 21.5 keV, as well 
photons at 60 keV with upper and lower discriminators set at 52 and 68 keV.  Although 
the AN/PDR-77 is not as widely available in forward deployed and combat areas as the 
AN/VDR-2, there is the potential to use this probe in the future to detect isotopes that 
55 
 
produce photons of low energy.  There is a Radiation Protection Officer (RPO) accessory 
kit which can also be used with the IM-263 from the AN/PDR-77.  This kit includes a 
pancake beta probe and micro-R probe.  The micro-R probe contains a 1” x 1.5” NaI 
scintillation crystal and 1” diameter PMT.  The x-ray probe and the micro-R probe can be 
modified for use with several portable multi-channel analyzers that are available 
commercially [24].   
 There is potential to model these additional probes in order to expand the 
capability to triage casualties who inhale isotopes of lower gamma ray energy compared 
those assessed in this research. 
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APPENDIX A  





Figure A.1 Distribution of 
137
Cs (Fast) in Female Phantom 
 
Figure A.2 Distribution of 
137


























































































Figure A.3 Distribution of 
60
Co in Female Phantom 
 
Figure A.4 Distribution of 
192










































































































































































































































Time Back Right Lung Neck Thigh
(Days) μGy/hr per Bq μGy/hr per Bq μGy/hr per Bq
0 7.10E-08 1.88E-08 2.62E-10
0.5 3.19E-07 2.76E-07 9.74E-08
1 3.67E-07 3.30E-07 1.18E-07
2 3.66E-07 3.37E-07 1.21E-07
3 3.55E-07 3.29E-07 1.19E-07
4 3.47E-07 3.23E-07 1.16E-07
5 3.41E-07 3.18E-07 1.14E-07
6 3.36E-07 3.14E-07 1.13E-07
7 3.33E-07 3.10E-07 1.12E-07
8 3.29E-07 3.07E-07 1.11E-07
9 3.27E-07 3.04E-07 1.10E-07
10 3.24E-07 3.02E-07 1.09E-07
12 3.19E-07 2.98E-07 1.07E-07
14 3.15E-07 2.93E-07 1.06E-07
20 3.03E-07 2.82E-07 1.02E-07















Time Back Right Lung Neck Thigh
(Days) μGy/hr per Bq μGy/hr per Bq μGy/hr per Bq
0 7.10E-08 1.88E-08 2.62E-10
0.5 9.77E-08 4.80E-08 1.52E-08
1 9.59E-08 5.51E-08 1.95E-08
2 8.71E-08 5.51E-08 1.89E-08
3 8.24E-08 5.38E-08 1.74E-08
4 8.03E-08 5.31E-08 1.66E-08
5 7.93E-08 5.28E-08 1.64E-08
6 7.88E-08 5.27E-08 1.63E-08
7 7.84E-08 5.27E-08 1.63E-08
8 7.82E-08 5.28E-08 1.63E-08
9 7.80E-08 5.29E-08 1.64E-08
10 7.78E-08 5.30E-08 1.65E-08
12 7.75E-08 5.32E-08 1.66E-08
14 7.73E-08 5.35E-08 1.68E-08
20 7.67E-08 5.43E-08 1.72E-08



























Time Back Right Lung Neck Thigh
(Days) μGy/hr per Bq μGy/hr per Bq μGy/hr per Bq
0 2.95E-07 8.49E-08 2.30E-09
0.5 1.54E-07 6.37E-08 2.17E-08
1 1.29E-07 6.56E-08 2.72E-08
2 1.04E-07 6.40E-08 2.48E-08
3 9.36E-08 6.11E-08 2.09E-08
4 8.86E-08 5.85E-08 1.84E-08
5 8.57E-08 5.64E-08 1.70E-08
6 8.36E-08 5.46E-08 1.61E-08
7 8.19E-08 5.30E-08 1.55E-08
8 8.03E-08 5.15E-08 1.49E-08
9 7.89E-08 5.03E-08 1.44E-08
10 7.76E-08 4.91E-08 1.40E-08
12 7.52E-08 4.71E-08 1.34E-08
14 7.31E-08 4.55E-08 1.28E-08
20 6.76E-08 4.20E-08 1.18E-08















Time Back Right Lung Neck Thigh
(Days) μGy/hr per Bq μGy/hr per Bq μGy/hr per Bq
0 1.01E-07 2.38E-08 2.14E-10
0.5 5.50E-08 1.89E-08 5.06E-09
1 4.77E-08 1.86E-08 6.22E-09
2 3.94E-08 1.71E-08 5.33E-09
3 3.59E-08 1.63E-08 4.39E-09
4 3.43E-08 1.59E-08 3.93E-09
5 3.34E-08 1.56E-08 3.74E-09
6 3.27E-08 1.54E-08 3.65E-09
7 3.21E-08 1.53E-08 3.61E-09
8 3.16E-08 1.51E-08 3.59E-09
9 3.11E-08 1.50E-08 3.57E-09
10 3.06E-08 1.48E-08 3.56E-09
12 2.97E-08 1.46E-08 3.54E-09
14 2.89E-08 1.43E-08 3.52E-09
20 2.65E-08 1.37E-08 3.45E-09

















Table A.5 Radiac Dose Rate Reading per CDL for Male with 
137




Table A.6 Radiac Dose Rate Reading per CDL for Male with 
137






Time Back Right Lung Front Right Lung Neck Thigh
(Days) mR/hr per CDL mR/hr per CDL mR/hr per CDL mR/hr per CDL
Class → F F F F
0 3.83E-01 3.53E-01 7.23E-02 1.01E-03
0.5 1.48E+00 1.58E+00 8.77E-01 5.76E-01
1 1.68E+00 1.80E+00 1.05E+00 6.97E-01
2 1.67E+00 1.79E+00 1.07E+00 7.17E-01
3 1.61E+00 1.74E+00 1.04E+00 7.02E-01
4 1.58E+00 1.70E+00 1.02E+00 6.89E-01
5 1.55E+00 1.67E+00 1.00E+00 6.78E-01
6 1.53E+00 1.65E+00 9.91E-01 6.69E-01
7 1.51E+00 1.63E+00 9.80E-01 6.62E-01
8 1.50E+00 1.61E+00 9.70E-01 6.56E-01
9 1.48E+00 1.60E+00 9.62E-01 6.50E-01
10 1.47E+00 1.59E+00 9.54E-01 6.45E-01
12 1.45E+00 1.56E+00 9.40E-01 6.35E-01
14 1.43E+00 1.54E+00 9.27E-01 6.26E-01
20 1.37E+00 1.48E+00 8.91E-01 6.02E-01















Time Back Right Lung Front Right Lung Neck Thigh
(Days) mR/hr per CDL mR/hr per CDL mR/hr per CDL mR/hr per CDL
Class → M M M M 
0 1.82E-01 1.67E-01 3.43E-02 4.78E-04
0.5 2.39E-01 2.37E-01 7.75E-02 4.07E-02
1 2.29E-01 2.29E-01 8.70E-02 5.28E-02
2 2.04E-01 2.05E-01 8.59E-02 5.18E-02
3 1.92E-01 1.93E-01 8.36E-02 4.82E-02
4 1.86E-01 1.88E-01 8.24E-02 4.64E-02
5 1.84E-01 1.85E-01 8.19E-02 4.57E-02
6 1.82E-01 1.84E-01 8.17E-02 4.56E-02
7 1.81E-01 1.83E-01 8.16E-02 4.56E-02
8 1.80E-01 1.82E-01 8.17E-02 4.57E-02
9 1.80E-01 1.82E-01 8.18E-02 4.59E-02
10 1.79E-01 1.82E-01 8.19E-02 4.61E-02
12 1.79E-01 1.81E-01 8.22E-02 4.66E-02
14 1.78E-01 1.80E-01 8.26E-02 4.70E-02
20 1.76E-01 1.79E-01 8.35E-02 4.83E-02

















Table A.7 Radiac Dose Rate Reading per CDL for Male with 
60




Table A.8 Radiac Dose Rate Reading per CDL for Male with 
192





Time Back Right Lung Front Right Lung Neck Thigh
(Days) mR/hr per CDL mR/hr per CDL mR/hr per CDL mR/hr per CDL
Class → M M M M 
0 7.27E-01 6.72E-01 1.55E-01 4.67E-03
0.5 4.12E-01 4.03E-01 1.09E-01 5.14E-02
1 3.60E-01 3.52E-01 1.09E-01 6.50E-02
2 3.03E-01 2.95E-01 1.04E-01 6.02E-02
3 2.76E-01 2.69E-01 9.86E-02 5.12E-02
4 2.62E-01 2.55E-01 9.44E-02 4.55E-02
5 2.53E-01 2.46E-01 9.09E-02 4.21E-02
6 2.46E-01 2.40E-01 8.80E-02 3.99E-02
7 2.40E-01 2.34E-01 8.55E-02 3.83E-02
8 2.35E-01 2.29E-01 8.33E-02 3.69E-02
9 2.31E-01 2.24E-01 8.13E-02 3.58E-02
10 2.27E-01 2.20E-01 7.95E-02 3.47E-02
12 2.19E-01 2.12E-01 7.64E-02 3.31E-02
14 2.12E-01 2.06E-01 7.38E-02 3.18E-02
20 1.96E-01 1.90E-01 6.81E-02 2.93E-02















Time Back Right Lung Front Right Lung Neck Thigh
(Days) mR/hr per CDL mR/hr per CDL mR/hr per CDL mR/hr per CDL
Class → M M M M 
0 4.75E-01 4.39E-01 7.84E-02 6.78E-04
0.5 2.58E-01 4.25E-01 5.77E-02 2.39E-02
1 2.20E-01 2.15E-01 5.57E-02 2.96E-02
2 1.80E-01 1.75E-01 5.03E-02 2.59E-02
3 1.63E-01 1.59E-01 4.76E-02 2.17E-02
4 1.55E-01 1.51E-01 4.62E-02 1.97E-02
5 1.51E-01 1.47E-01 4.54E-02 1.88E-02
6 1.48E-01 1.44E-01 4.48E-02 1.85E-02
7 1.45E-01 1.42E-01 4.43E-02 1.83E-02
8 1.43E-01 1.39E-01 4.38E-02 1.82E-02
9 1.40E-01 1.37E-01 4.34E-02 1.81E-02
10 1.38E-01 1.35E-01 4.29E-02 1.80E-02
12 1.34E-01 1.31E-01 4.21E-02 1.79E-02
14 1.30E-01 1.27E-01 4.14E-02 1.78E-02
20 1.19E-01 1.17E-01 3.93E-02 1.75E-02

















Table A.9 Radiac Dose Rate Reading per CDL for Female with 
137









Time Back Right Lung Neck Thigh
(Days) μGy/hr per CDL μGy/hr per CDL μGy/hr per CDL
Class → F F F
0 3.86E+00 1.02E+00 1.42E-02
0.5 1.73E+01 1.50E+01 5.29E+00
1 1.99E+01 1.79E+01 6.40E+00
2 1.99E+01 1.83E+01 6.57E+00
3 1.93E+01 1.79E+01 6.44E+00
4 1.89E+01 1.75E+01 6.32E+00
5 1.85E+01 1.73E+01 6.22E+00
6 1.83E+01 1.70E+01 6.14E+00
7 1.81E+01 1.69E+01 6.07E+00
8 1.79E+01 1.67E+01 6.01E+00
9 1.77E+01 1.65E+01 5.96E+00
10 1.76E+01 1.64E+01 5.91E+00
12 1.73E+01 1.62E+01 5.83E+00
14 1.71E+01 1.59E+01 5.75E+00
20 1.65E+01 1.53E+01 5.52E+00















Time Back Right Lung Neck Thigh
(Days) μGy/hr per CDL μGy/hr per CDL μGy/hr per CDL
Class → M M M
0 1.83E+00 1.08E+00 1.50E-02
0.5 2.52E+00 1.24E+00 3.91E-01
1 2.47E+00 1.42E+00 5.03E-01
2 2.24E+00 1.42E+00 4.86E-01
3 2.12E+00 1.39E+00 4.48E-01
4 2.07E+00 1.37E+00 4.29E-01
5 2.04E+00 1.36E+00 4.22E-01
6 2.03E+00 1.36E+00 4.19E-01
7 2.02E+00 1.36E+00 4.19E-01
8 2.01E+00 1.36E+00 4.21E-01
9 2.01E+00 1.36E+00 4.22E-01
10 2.01E+00 1.37E+00 4.24E-01
12 2.00E+00 1.37E+00 4.28E-01
14 1.99E+00 1.38E+00 4.32E-01
20 1.98E+00 1.40E+00 4.44E-01




























Time Back Right Lung Neck Thigh
(Days) μGy/hr per CDL μGy/hr per CDL μGy/hr per CDL
Class → M M M
0 7.37E+00 2.12E+00 5.74E-02
0.5 3.86E+01 3.33E+01 1.18E+01
1 4.43E+01 3.99E+01 1.42E+01
2 4.42E+01 4.08E+01 1.46E+01
3 4.29E+01 3.98E+01 1.43E+01
4 4.20E+01 3.90E+01 1.41E+01
5 4.13E+01 3.84E+01 1.38E+01
6 4.07E+01 3.79E+01 1.37E+01
7 4.02E+01 3.75E+01 1.35E+01
8 3.99E+01 3.71E+01 1.34E+01
9 3.95E+01 3.68E+01 1.33E+01
10 3.92E+01 3.65E+01 1.32E+01
12 3.86E+01 3.60E+01 1.30E+01
14 3.81E+01 3.55E+01 1.28E+01
20 3.66E+01 3.41E+01 1.23E+01















Time Back Right Lung Neck Thigh
(Days) μGy/hr per CDL μGy/hr per CDL μGy/hr per CDL
Class → M M M
0 4.85E+00 1.14E+00 1.03E-02
0.5 2.65E+00 9.09E-01 2.43E-01
1 2.29E+00 8.96E-01 2.99E-01
2 1.89E+00 8.23E-01 2.56E-01
3 1.73E+00 7.83E-01 2.11E-01
4 1.65E+00 7.63E-01 1.89E-01
5 1.61E+00 7.51E-01 1.80E-01
6 1.57E+00 7.42E-01 1.76E-01
7 1.55E+00 7.34E-01 1.74E-01
8 1.52E+00 7.27E-01 1.73E-01
9 1.50E+00 7.20E-01 1.72E-01
10 1.47E+00 7.13E-01 1.71E-01
12 1.43E+00 7.01E-01 1.70E-01
14 1.39E+00 6.89E-01 1.69E-01
20 1.27E+00 6.57E-01 1.66E-01

















Table A.13 Radiac Dose Rate Reading per CDL for Female with 
137









Time Back Right Lung Neck Thigh
(Days) mR/hr per CDL mR/hr per CDL mR/hr per CDL
Class → F F F
0 3.86E-01 1.02E-01 1.42E-03
0.5 1.73E+00 1.50E+00 5.29E-01
1 1.99E+00 1.79E+00 6.40E-01
2 1.99E+00 1.83E+00 6.57E-01
3 1.93E+00 1.79E+00 6.44E-01
4 1.89E+00 1.75E+00 6.32E-01
5 1.85E+00 1.73E+00 6.22E-01
6 1.83E+00 1.70E+00 6.14E-01
7 1.81E+00 1.69E+00 6.07E-01
8 1.79E+00 1.67E+00 6.01E-01
9 1.77E+00 1.65E+00 5.96E-01
10 1.76E+00 1.64E+00 5.91E-01
12 1.73E+00 1.62E+00 5.83E-01
14 1.71E+00 1.59E+00 5.75E-01
20 1.65E+00 1.53E+00 5.52E-01















Time Back Right Lung Neck Thigh
(Days) mR/hr per CDL mR/hr per CDL mR/hr per CDL
Class → M M M
0 1.83E-01 1.08E+00 1.50E-02
0.5 2.52E-01 1.24E+00 3.91E-01
1 2.47E+00 1.42E+00 5.03E-01
2 2.24E+00 1.42E+00 4.86E-01
3 2.12E+00 1.39E+00 4.48E-01
4 2.07E+00 1.37E+00 4.29E-01
5 2.04E+00 1.36E+00 4.22E-01
6 2.03E+00 1.36E+00 4.19E-01
7 2.02E+00 1.36E+00 4.19E-01
8 2.01E+00 1.36E+00 4.21E-01
9 2.01E+00 1.36E+00 4.22E-01
10 2.01E+00 1.37E+00 4.24E-01
12 2.00E+00 1.37E+00 4.28E-01
14 1.99E+00 1.38E+00 4.32E-01
20 1.98E+00 1.40E+00 4.44E-01




























Time Back Right Lung Neck Thigh
(Days) mR/hr per CDL mR/hr per CDL mR/hr per CDL
Class → M M M 
0 7.37E-01 2.12E-01 5.74E-03
0.5 3.84E-01 1.59E-01 5.42E-02
1 3.23E-01 1.64E-01 6.79E-02
2 2.60E-01 1.60E-01 6.20E-02
3 2.34E-01 1.53E-01 5.22E-02
4 2.22E-01 1.46E-01 4.61E-02
5 2.14E-01 1.41E-01 4.26E-02
6 2.09E-01 1.36E-01 4.03E-02
7 2.05E-01 1.32E-01 3.86E-02
8 2.01E-01 1.29E-01 3.73E-02
9 1.97E-01 1.26E-01 3.61E-02
10 1.94E-01 1.23E-01 3.51E-02
12 1.88E-01 1.18E-01 3.34E-02
14 1.83E-01 1.14E-01 3.21E-02
20 1.69E-01 1.05E-01 2.96E-02















Time Back Right Lung Neck Thigh
(Days) mR/hr per CDL mR/hr per CDL mR/hr per CDL
Class → M M M 
0 4.85E-01 1.14E-01 1.03E-03
0.5 2.65E-01 9.09E-02 2.43E-02
1 2.29E-01 8.96E-02 2.99E-02
2 1.89E-01 8.23E-02 2.56E-02
3 1.73E-01 7.83E-02 2.11E-02
4 1.65E-01 7.63E-02 1.89E-02
5 1.61E-01 7.51E-02 1.80E-02
6 1.57E-01 7.42E-02 1.76E-02
7 1.55E-01 7.34E-02 1.74E-02
8 1.52E-01 7.27E-02 1.73E-02
9 1.50E-01 7.20E-02 1.72E-02
10 1.47E-01 7.13E-02 1.71E-02
12 1.43E-01 7.01E-02 1.70E-02
14 1.39E-01 6.89E-02 1.69E-02
20 1.27E-01 6.57E-02 1.66E-02
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